Michael Frumovitz

[Shelley LM @ShelleyMLM]

The call for proposals is just days away! Mucinous Ovarian Cancer Coalition/MOCC invites researchers to submit abstracts for requests of up to $50,000. Find the full guidelines here: https://t.co/9CQUvByhpp
@Frumovitz @katiekurnit @JennyMueller_ @SGO_org

[Michael Frumovitz @Frumovitz]

We now have FOUR potential clinical trials open at @MDAndersonNews for patients with small cell/large cell/neuroendocrine cervical cancer. Both targeted and immunotherapies. Excited to offer so many opportunities to patients with this rare cancer @SARCC @LaurenByersMD

[IJGC @IJGConline]

Clinicopathologic characteristics, oncologic outcomes & prognostic factors in #neuroendocrine #CervicalCarcinoma #NECTURstudy
@ajhingran @MDAndersonNews @frumovitz

https://t.co/cet8ATJXMJ

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert

[Dana Hazimeh @danahazime1]

Honored to receive the Felix Rutledge Society travel award and excited to be presenting my research at this year’s annual @WAGO_org meeting!
I am so grateful for my Hopkins family and amazing mentors 😊

@HopkinsGynOnc
@MDAndersonNews

[Elsevier for Medical Professionals @Elsevier_Med]

“This is likely the most comprehensive book for these rare gynecological cancers.” -©Doody’s Review Service, 2023. Read full review: https://t.co/3B1ptlSort
@frumovitz, @leitaomd, @NancyDEditor

[Shelley LM @ShelleyMLM]

The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce "Rhonda's Award 2023" is now open. We will accept submissions for grants up to $50,000. Focus must be on #MucinousOvarianCancer Find more details here: https://t.co/9CQUvByhpp

[Elsevier for Medical Professionals @Elsevier_Med]

“Both the physical textbook and the ebook achieve this goal and provide guidance from workup to primary treatment to recurrence and surveillance strategies.” -©Doody’s Review Service, 2023. Read full review: https://t.co/3McKV1UJY5
@frumovitz @leitaomd @NancyDEditor

[Mario M. Leitao, Jr @leitaomd]

Diagnosis and Treatment of Rare Gynecologic Cancers https://t.co/cjkBmQ5ttL #Amazon

[Beth Comcowich Garcia @BethGarciaMDA]

Patient Experience rounds are back @MDAndersonNews with @Frumovitz CPXO. Outstanding work going on in Head and Neck Center improving responsiveness and informing about wait times. Their scores reflect their hard work! All domains reached goal this quarter! #ServiceExcellence

[Michael Frumovitz @Frumovitz]

@cgmd33 @pedroramirezMD Was it just one slide that said “It doesn’t work”?

[Michael Frumovitz @Frumovitz]

So excited to be at the @Allyson4Rare gala in support of young people with cancer. So appreciative of their amazing support of our #NECC research. @MDAndersonNews @SCCCLCCCSisters

[Shelley LM @ShelleyMLM]

The Mucinous Ovarian Cancer Coalition (MOCC) is pleased to announce Dr. Kylie Gorringe as the recipient of Rhonda's Award. Find all of the details about this annual grant and Dr. Gorringe here: https://t.co/Lq0WMZ7VIE
@Frumovitz @JennyMueller_ @katiekurnit

[Shelley LM @ShelleyMLM]

The deadline to apply for up to $50,000 to fund research on mucinous ovarian cancer is July 14th. Find details about Rhonda's Award here: https://t.co/9CQUvByhpp
@Frumovitz @JennyMueller_ @katiekurnit

[Michael Frumovitz @Frumovitz]

$50K Rhonda’s Award to support research in mucinous ovarian cancer now being offered by the Mucinous Ovarian Cancer Coalition/MOCC. Details/deadlines here: https://t.co/8MN4NHQ7De Great opportunity for research in this #raretumor @SGO_org @ESGO_society @IGCSociety @ShelleyMLM

[Katie Kurnit @katiekurnit]

Excited to share a new research award for mucinous ovarian cancer! Application now open, deadline on 6/2. Can’t wait to make some much needed progress for this #raretumor @ShelleyMLM @Frumovitz @JennyMueller_ https://t.co/Yhm1cCE5LG

[Shelley LM @ShelleyMLM]

We are the Mucinous Ovarian Cancer Coalition. Launched by my late sister in September of 2020. In addition to financial supportnd opinions, and resources, we fund research grants. RFPs for Rhonda’s Award begins on June 2nd for grants up to $50k. https://t.co/tFgEAIE4kv #gyncsm

[Michael Frumovitz @Frumovitz]

Our trial with immunotherapy AK104 (cadonilimab) for women with neuroendocrine cervix cancer at @MDAndersonNews opened just this week! We already have 1 enrolled and 2 in screening. Trials for #raretumors are possible! @SGO_org @NANETS1 @SCCCLCCCSisters @ShannonWestin @karenluMD

[Michael Frumovitz @Frumovitz]

Stay tuned! Our trial with AK104 (cadonilimab), a bispecific PD1/CTLA4 antibody, for women with neuroendocrine cervical cancer should open next week! So close!! @SCCCLCCCSisters @SGO_org @NANETS1

[Ashley Alexander @AshAlexander44]

Health care providers, join us tonight’s Physician Advisory Council meeting, where we will be joined by MD Anderson President Dr. Peter WT Pisters. The virtual event is from 6-7 p.m. CST. Register here: https://t.co/ZWGSnANhJC @PPisters #EndCancer

[Michael Frumovitz @Frumovitz]

@SKS1377 @MDAndersonNews @zivanovicmd @JennyMueller_ @ShelleyMLM @katiekurnit @AnilSoodMD This trial is open to patients from outside the US although it may not be covered by your insurance like it likely will be for women with US insurance

[Michael Frumovitz @Frumovitz]

Excited to announce our clinical trial with surgery and #HIPEC for recurrent mucinous ovarian cancer is now open at @MDAndersonNews. Will also open at MSKCC later this year with our colleagues @zivanovicmd and @JennyMueller_. @ShelleyMLM @katiekurnit @AnilSoodMD